Researchers at The Ottawa Hospital awarded 15 CIHR grants worth more than $8.4 million
February 3, 2023 - Researchers at The Ottawa Hospital are playing a lead role in 15 new projects awarded more than $8.4 million from the Canadian Institutes of Health Research (CIHR). |
Researchers update guidance on colorectal cancer screening in patients with IBDs
November 4, 2021 - Dr. Sanjay Murthy was the lead author in a Clinical Practice Update (CPU) for the American Gastroenterological Association on how to prevent, detect and manage colorectal neoplastic lesions in patients with inflammatory bowel diseases (IBDs) ... |
Are we using biologic therapy properly?
June 13, 2019 - The introduction of infliximab (Remicade), the first biologic therapy approved for the treatment of inflammatory bowel diseases (IBD), did not result in lower rates of hospitalizations or intestinal surgeries among patients living with IBD in ... |
Clinical trials offer strong foundation for better patient care
May 16, 2019 - Clinical trials are an important step toward developing new treatments and learning more about diseases and conditions. In honour of International Clinical Trials Day, read how some of the researchers at The Ottawa Hospital are making huge ... |
Researchers to advance science and improve health with new CIHR funding
February 14, 2019 - Researchers at The Ottawa Hospital, affiliated with the University of Ottawa, are playing a lead role in nine new projects funded by the Canadian Institutes of Health Research (CIHR). These projects will advance science and improve health in ... |
$1.7 million to advance research on colon cancer, brain development, kidney disease and severe fluid loss
July 20, 2018 - Four research groups at The Ottawa Hospital, affiliated with the University of Ottawa, have been awarded $1.7 million in the most recent project grant competition from the Canadian Institutes of Health Research (CIHR). Their projects will advance ... |
Colonoscopies save lives, but study finds room for improvement
May 16, 2018 - Colorectal cancer (CRC) is the third most common cancer in Canada. Colonoscopy can reduce the risks of CRC and CRC-related death through early detection and treatment of pre-cancerous growth. A new study led by Dr. Sanjay Murthy found that while co |
